Literature DB >> 15864193

Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis.

Pierre Nahon1, Nathalie Ganne-Carrié, Françoise Degos, Karine Nahon, Jacques Paries, Véronique Grando, Cendrine Chaffaut, Corinne Njapoum, Christos Christidis, Jean-Claude Trinchet, Sylvie Chevret, Michel Beaugrand.   

Abstract

AIM: The presence of esophageal varices has been reported to be a prognostic factor in patients with compensated hepatitis viral C induced cirrhosis. We studied the prognostic value of hepatic venous pressure gradient in addition to epidemiological and clinical parameters in these patients.
METHODS: Among patients with Child-Pugh A hepatitis C induced cirrhosis, prospectively followed in two Parisian centres, 100 had measurement of occluded and free hepatic venous pressures. We evaluated hepatic venous pressures as a predictive factor of death by Cox models (survival) and Fine and Gray models (liver-deaths).
RESULTS: Median hepatic occluded pressure and gradient were 21.5 (15-24) and 13 mm Hg (9-15), respectively. The median duration of follow-up was 85 months (range: 70-112); 38 deaths or liver transplantation were registered. Hepatic venous pressure gradient was not significantly related to survival in the studied population but as a continuous variable was predictive of death from liver disease. On multivariable analysis serum albumin <40 g/L and platelet count <90,000 /mm(3) were the only selected prognostic factors.
CONCLUSION: Hepatic venous pressure gradient has a limited value for assessing the prognosis of patients with Child-Pugh A hepatitis C virus induced cirrhosis; prognosis is accurately predicted by serum albumin and platelet count.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864193     DOI: 10.1016/s0399-8320(05)80779-1

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

1.  Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis.

Authors:  Cristina Ripoll; Khurram Bari; Guadalupe Garcia-Tsao
Journal:  J Clin Gastroenterol       Date:  2015-08       Impact factor: 3.062

Review 2.  Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Sumit Dahal; Smrity Upadhyay; Rashmi Banjade; Prajwal Dhakal; Nabin Khanal; Vijaya Raj Bhatt
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-03-01       Impact factor: 2.576

3.  Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.

Authors:  Bernhard Scheiner; Lisa Steininger; Georg Semmler; Lukas W Unger; Philipp Schwabl; Theresa Bucsics; Rafael Paternostro; Arnulf Ferlitsch; Michael Trauner; Thomas Reiberger; Mattias Mandorfer
Journal:  Liver Int       Date:  2018-09-22       Impact factor: 5.828

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.